In a filing, Steris Plc revealed its Officer Madsen Julia acquired Company’s shares for reported $1.31 million on Nov 21 ’25. In the deal valued at $262.00 per share,5,008 shares were bought.
Then, Tamaro Renato sold 5,036 shares, generating $1,297,040 in total proceeds. Upon selling the shares at $257.55, the V.P. & Corporate Treasurer now owns 5,695 shares.
Before that, Tamaro Renato bought 5,036 shares. Steris Plc shares valued at $1,297,033 were divested by the Officer at a price of $257.55 per share.
Morgan Stanley upgraded its Steris Plc [STE] rating to an Overweight from a an Equal-weight in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in late May with a ‘”a Hold”‘ rating. Piper Sandler also remained covering STE and has increased its forecast on October 24, 2024 with a “an Overweight” recommendation from previously “Neutral” rating.
Price Performance Review of STE
On Monday, Steris Plc [NYSE:STE] saw its stock fall -0.08% to $263.08. Over the last five days, the stock has gained 2.36%. Steris Plc shares have risen nearly 23.95% since the year began. Nevertheless, the stocks have risen 27.98% over the past one year. While a 52-week high of $268.30 was reached on 11/12/25, a 52-week low of $200.98 was recorded on 01/03/25.
Levels Of Support And Resistance For STE Stock
The 24-hour chart illustrates a support level at 261.66, which if violated will result in even more drops to 260.24. On the upside, there is a resistance level at 264.92. A further resistance level may holdings at 266.76.
How much short interest is there in Steris Plc?
A steep rise in short interest was recorded in Steris Plc stocks on 2025-10-31, dropping by -0.16 million shares to a total of 0.96 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 1.12 million shares. There was a decline of -17.14%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on May 30, 2023 when Morgan Stanley began covering the stock and recommended ‘”an Equal-weight”‘ rating along with a $206 price target.
